Status:
COMPLETED
A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD)
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Brief Summary
A real world study to determine the effectiveness of a patient support service to aid COPD patients in their self management.
Detailed Description
The purpose of the study is to evaluate a digital health wellness support tool for patients in primary care with COPD using a smart mobile app, patient web portal and technology attached to the patien...
Eligibility Criteria
Inclusion
- Clinical diagnosis of COPD
- FEV1/FVC ratio \>0.3-\<0.7 and FEV1 \> 30% post-bronchodilator
- Prescribed either ICS, LABA and or LAMA at dose for COPD
- Exacerbations reported within the last 12 months requiring treatment with \>1 systemic steroid and/or antibiotics, OR hospitalisation within last 12 months due to exacerbation, OR have received \>12 SABA prescriptions in previous 12 months
- Patient has a self management plan which includes use of an oral steroid at a dose within NICE guidelines, and additionally antibiotics as appropriate.
Exclusion
- Symptomatic asthma or seasonal allergic rhinitis leading to hospitalisation in previous 12 months
- Patients unable to use a mobile phone
Key Trial Info
Start Date :
October 26 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 23 2018
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT02300090
Start Date
October 26 2016
End Date
August 23 2018
Last Update
September 11 2018
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
East Cheshire, UK, United Kingdom, CW12 1JN
2
Research Site
East Cheshire, UK, United Kingdom, SK10 5JH
3
Research Site
East Cheshire, UK, United Kingdom, SK11 6JL
4
Research Site
East Cheshire, UK, United Kingdom, SK12 1EU